Voyager Therapeutics Stock Analysis

Voyager Stock Analysis Notes

About 64.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 0.72. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Voyager Therapeutics recorded a loss per share of 1.13. The entity had not issued any dividends in recent years. Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Voyager Therapeut operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people. For more information please call Sandrock MD at 857 259 5340 or visit https://www.voyagertherapeutics.com.

Voyager Therapeutics Investment Alerts

Voyager Therapeutics Upcoming and Recent Events

Voyager Largest EPS Surprises

View All Earnings Estimates

Voyager Therapeutics Environmental, Social, and Governance (ESG) Scores

Voyager Stock Institutional Investors

Note, although Voyager Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Voyager Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 215.86 M.

Voyager Profitablity

The company has Profit Margin (PM) of (0.81) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (6.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $6.1.

Management Efficiency

Voyager Therapeutics has return on total asset (ROA) of (0.1399) % which means that it has lost $0.1399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2425) %, meaning that it created substantial loss on money invested by shareholders. Voyager Therapeutics' management efficiency ratios could be used to measure how well Voyager Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/25/2025, Return On Tangible Assets is likely to drop to -0.17. In addition to that, Return On Capital Employed is likely to drop to -0.25. At this time, Voyager Therapeutics' Non Current Assets Total are relatively stable compared to the past year. As of 03/25/2025, Non Currrent Assets Other is likely to grow to about 72 M, while Other Assets are likely to drop 1.09.

Technical Drivers

As of the 25th of March, Voyager Therapeutics has the Variance of 13.96, coefficient of variation of (542.60), and Risk Adjusted Performance of (0.16). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Voyager Therapeutics, as well as the relationship between them. Please validate Voyager Therapeutics market risk adjusted performance and treynor ratio to decide if Voyager Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 3.91 per share. Given that Voyager Therapeutics has information ratio of (0.18), we advise you to double-check Voyager Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Voyager Therapeutics Price Movement Analysis

Voyager Therapeutics Insider Trading Activities

Voyager Therapeutics Outstanding Bonds

Voyager Therapeutics Predictive Daily Indicators

Voyager Therapeutics Corporate Filings

Voyager Therapeutics Forecast Models

Voyager Therapeutics' time-series forecasting models are one of many Voyager Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Voyager Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Voyager Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Voyager shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Voyager Therapeutics. By using and applying Voyager Stock analysis, traders can create a robust methodology for identifying Voyager entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Voyager analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Voyager analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Voyager Therapeutics stock analysis indicators help investors evaluate how Voyager Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Voyager Therapeutics shares will generate the highest return on investment. By understating and applying Voyager Therapeutics stock analysis, traders can identify Voyager Therapeutics position entry and exit signals to maximize returns.

When running Voyager Therapeutics' price analysis, check to measure Voyager Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyager Therapeutics is operating at the current time. Most of Voyager Therapeutics' value examination focuses on studying past and present price action to predict the probability of Voyager Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyager Therapeutics' price. Additionally, you may evaluate how the addition of Voyager Therapeutics to your portfolios can decrease your overall portfolio volatility.